Medigus (MDGS) Announces Proposed Public Offering of ADSs, Warrants

Medigus Ltd. (NASDAQ: MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced that it intends to offer and sell American Depositary Shares and pre-funded warrants in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Medigus intends to use the net proceeds from the proposed offering for working capital and general corporate purposes.

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering.

A shelf registration statement on Form F-3 (File No. 333-238162) relating to the securities to be issued in the proposed offering was filed with the Securities and Exchange Commission (SEC) and is effective.

You May Also Be Interested In

• Nauticus Robotics signs non-binding $50M investment letter of intent
• ADARx Pharmaceuticals prices $446.3M IPO at $17 per share
• J&J myeloma drug shows 5-year remission in half of early-line patients